Sanlam has written its AfroCentric stake down to nil after the Bonitas exit but rules out a sale, betting it can revive the business.
You must be a subscriber to access all of this content.
Portugal's FHC is entering South Africa's sterile injectables market, planning to build a local plant to challenge established players.
You must be a subscriber to access all of this content.
Discover how AfroCentric results indicate strong revenue growth while navigating a R1.27bn loss through strategic changes.
You must be a subscriber to access all of this content.
Get insights into the Bonitas Tender Dispute as Bonitas reacts to Medscheme’s challenge over service provider appointments.
You must be a subscriber to access all of this content.
Bonitas Medscheme split sees Momentum Health and PHA take over key contracts, as a CMS forensic probe and court action continue.
You must be a subscriber to access all of this content.